| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Ingeborg M van Geijlswijk | Q45987914 |
| Wiebe Braam | Q58810820 | ||
| P2093 | author name string | Leopold M G Curfs | |
| Hubert Korzilius | |||
| Robert Didden | |||
| Marcel G Smits | |||
| P2860 | cites work | Melatonin for treatment of sleep disorders in children with developmental disabilities. | Q43711266 |
| Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia | Q44575666 | ||
| Effects of a low dose of melatonin on sleep in children with Angelman syndrome | Q48171924 | ||
| P433 | issue | 5 | |
| P921 | main subject | disability | Q12131 |
| disability affecting intellectual abilities | Q3317827 | ||
| melatonin | Q180912 | ||
| intellectual disability | Q183560 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 340-349 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Developmental Medicine and Child Neurology | Q15716651 |
| P1476 | title | Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis | |
| P478 | volume | 51 |
| Q28661706 | Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives |
| Q47685588 | Analysis of Different Melatonin Secretion Patterns in Children With Sleep Disorders: Melatonin Secretion Patterns in Children |
| Q40493466 | Analysis on nutritional risk screening and influencing factors of hospitalized patients in central urban area |
| Q39012491 | Angelman syndrome: Current and emerging therapies in 2016. |
| Q28080719 | Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives |
| Q38764691 | Behavioural interventions for sleep problems in people with an intellectual disability: a systematic review and meta-analysis of single case and group studies |
| Q34135759 | British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. |
| Q48232008 | CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder? |
| Q48207652 | Central sleep apnea: does stabilizing sleep improve it? |
| Q36226150 | Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review |
| Q37348984 | Chronicity of sleep problems in children with chronic illness: a longitudinal population-based study |
| Q26861877 | Circadian rhythm abnormalities |
| Q21296744 | Clinical uses of melatonin in pediatrics |
| Q37691012 | Developmental Programming of Adult Disease: Reprogramming by Melatonin? |
| Q36735320 | Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin |
| Q48256192 | Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study |
| Q47628865 | European guideline for the diagnosis and treatment of insomnia |
| Q27012836 | Melatonin Treatment in Children with Developmental Disabilities |
| Q47555093 | Melatonin and Angelman Syndrome: Implications and Mathematical Model of Diurnal Secretion |
| Q64950590 | Melatonin and Expression of Tryptophan Decarboxylase Gene (TDC) in Herbaceous Peony (Paeonia lactiflora Pall.) Flowers. |
| Q48109920 | Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action |
| Q47975631 | Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study |
| Q36372805 | Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial |
| Q27303807 | Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study |
| Q37091140 | Melatonin improves sleep quality in hemodialysis patients |
| Q64911871 | Melatonin in Critically Ill Children. |
| Q33655732 | Melatonin in Tuberous Sclerosis Complex Analysis Using Modern Mathematical Modeling Methods |
| Q37138835 | Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trial |
| Q28386102 | Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability |
| Q46368852 | Pharmacological therapies for Angelman syndrome |
| Q47619565 | Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities |
| Q26827423 | Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes |
| Q92138498 | Protocol: Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease |
| Q92967028 | Review of Narcolepsy and Other Common Sleep Disorders in Children |
| Q90584558 | Selecting a pharmacotherapy regimen for patients with chronic insomnia |
| Q64130466 | Sleep Problems in 2- to 5-Year-Olds With Autism Spectrum Disorder and Other Developmental Delays |
| Q83649119 | Sleep disorders in children |
| Q41486105 | Sleep in Autism Spectrum Disorders |
| Q33655855 | Sleep in Neurodevelopmental Disorders. |
| Q38397364 | Systematic Reviews of the Health or Health care of People with Intellectual Disabilities: A Systematic Review to Identify Gaps in the Evidence Base |
| Q42689806 | Unmet clinical needs and burden in Angelman syndrome: a review of the literature |
Search more.